CDI Bioscience

CDI Bioscience has developed an innovative technology to enhance the yield of bioproducts produced in cellular systems. Genetic engineering techniques are employed to regulate cellular metabolism, shifting cells from replication mode to production mode (RPShift®). Specifically, this technology is designed for mammalian cells, unlocking their potential to produce proteins, peptides, and enzymes. The current design of this technology can be readily adapted to bacterial and yeast cell systems for the production of commercial-grade bioproducts.